Cookies on this site

Professor Andrew Sharott (Team leader) and Professor Laura Parkkinen (Co-Investigator) from Nuffield Department of Clinical Neurosciences (NDCN) have been selected for multi-year grants to join the Collaborative Research Network (CRN) an international, multidisciplinary, multi-institutional network working to address high-priority research questions about Parkinson's disease.

ASAP project leads Andy Sharott and Laura Parkkinen

Awarded by Aligning Science Across Parkinson’s (ASAP), in partnership with The Michael J. Fox Foundation for Parkinson’s Research (MJFF), the two grants of $9 million each will support research aimed at addressing key gaps in understanding the development and progression of Parkinson’s disease.

Parkinson’s disease (PD) is one of the fastest growing neurological disorders in the world, yet there are no treatments that can slow or cure the condition. The CRN brings together leading researchers around the world with the aim of mapping the biological blueprint of Parkinson’s disease and building a standardised toolkit of global research resources to help turn discoveries into treatments.

This next phase of the CRN initiative focuses on understanding why Parkinson’s disease varies across individuals, and advancing discoveries toward more precise diagnostics and therapies for patients.

Professor Andrew Sharott, who is Associate Director of the MRC CoRE in Restorative Neural Dynamics, will be the Lead-Investigator on a team examining whether different sleep problems in Parkinson’s are caused by specific disruptions to distinct brain oscillations.  Working in collaboration with Dr Angelina Maric and Dr Daniela Noain ( University of Zurich) Professor Derk -Jan Dijk (University of Surrey) and Professor Aleksandar Videnovic (Massachusetts General Hospital/Harvard University), the team will test whether restoring these activities to their healthy state will improve these specific aspects of sleep and slow down the progression of nerve cell loss. 

Professor Laura Parkkinen, Professor of Translational Neuropathology and Director of the Oxford Brain Bank, who is also a Group Leader at the new UK DRI Parkinson’s disease Centre, will serve as a Co-Investigator on a team examining the role of a-synuclein and protein misfolding in the development and progression of Parkinson’s disease. Working in collaboration with Professors Matthias Mann (Max Planck Institute of Biochemistry) and Günter Höglinger and Franziska Hopfner (LMU University Hospital), the team aims to understand why Parkinson's progresses so differently between patients despite shared clinical and pathological features.

Read the full story on the Nuffield Department of Clinical Neurosciences website. 

Similar stories

Research shows for the first time that standard non-contrast CT scans can be analysed by AI to reveal hidden coronary inflammation

Researchers from 27 institutions across UK, USA, Europe and Australia, led by a team at the University of Oxford, have demonstrated how an AI technology can measure inflammation in the heart’s arteries using low-radiation CT heart scans typically used to measure calcium score.

Five European Research Council (ERC) Synergy Grants awarded to Oxford researchers for ambitious new collaborations

Five Oxford University academics are to co-lead ambitious new research projects backed by European Research Council (ERC) Synergy Grants, part of the EU’s Horizon Europe research and innovation programme. Synergy Grants support groups of two to four outstanding researchers who combine complementary expertise and resources to tackle ambitious scientific challenges that could not be addressed by individual teams alone.

Professor Ole Jensen (Department of Experimental Psychology) and colleagues received €13.6 million to discover when the brain is ready for language and social understanding

The team will use new wearable brain sensors to track cognitive development from before birth to eight years of age.

New 'molecular glue' helps break down antibiotic resistance enzymes in E. coli

Oxford University scientists have discovered a new approach to tackle antimicrobial resistance (AMR), using 'molecular glues' to encourage bacteria to destroy their own resistance-causing enzymes. The study has been published in Angewandte Chemie International Edition.

Stronger immune system may help protect against prostate cancer

Higher levels of proteins involved in activating and coordinating the immune system were associated with a lower risk of developing prostate cancer, in a new study led by researchers at the Nuffield Department of Population Health.

The Nuffield Department of Women's & Reproductive Health has published its Biennial Report 2024–26

The Biennial Report 2024–26 highlights two years of research excellence, innovation, collaboration and growth.